AIDS WEEKLY Plus - November 2002Important note: Information in this article was accurate in November 2002. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

HIV/AIDS Pathogenesis: Myeloid-related proteins play key role in viral replication

AIDSWEEKLY Plus; November 25, 2002
Michael Greer, Senior Medical Writer


NewsRx -- Researchers in Canada have identified a set of cellular proteins that appear to play a key role in the process of HIV replication.

"S100A8, S100A9, and S100A12, collectively known as myeloid-related proteins (MRPs), are highly expressed by the myeloid cell lineage and are found in the extracellular milieu during infections and inflammatory conditions," according to Carle Ryckman and colleagues at the University Hospital Complex of Quebec and the University of Laval in St. Foy.

These proteins trigger HIV genetic activity necessary for viral replication, Ryckman and coauthors found.

Previous studies had shown that MRP levels were significantly elevated in HIV patients, the researchers said. These studies also revealed that MRP serum concentrations were correlated with the extent of CD4 cell depletion.

Ryckman and coauthors treated latently infected human T cells with MRPs, which augmented viral replication by up to five times, according to the report. Genetic assays showed that these proteins activate the HIV long terminal repeat (LTR) promoter, and that this effect could be prevented by MRP-specific antibodies.

MRP-induced promoter activity required the viral enhancer sequence and the transcription factor nuclear factor-kappaB (HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. J Immunol 2002 Sep 15;169(6):3307-13.

Ryckman and colleagues concluded that "MRPs induce HIV-1 transcriptional activity and viral replication in infected CD4+ T-lymphocytes at concentrations similar to those found in the serum of HIV-1-infected patients."

The corresponding author for this report is Philippe A. Tessier, Centre de Recherche en Infectiologie, Pavillon Centre Hospitalier de l'Universite Laval, Centre Hospitalier Universitaire de Quebec, 2705 Blvd., St Foy, PQ G1V 4G2, Canada. E-mail: Philippe.Tessier@crchul.ulaval.ca.

Key points reported in this study include:

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Ryckman C, Robichaud GA, Roy J, et al., "HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes", J Immunol 2002 Sep 15;169(6):3307-13.

021125
AW021110


Copyright © 2002 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.